Evaluation of IRI Prevention in Liver Transplantation with Infliximab (anti-TNF): preliminary results in a study group of patients with MELD>30

Paolo Girotti, Alfred Königsrainer & Silvio Nadalin
Introduction: Ischemia-Reperfusion Injury (IRI) represents a complex series of intracellular and extracellular events that results in molecular, cellular and tissue damage. It´s induced by the transient deprivation of blood flow and oxygen, with lack of aerobic methabolism, and the return of [for full text, please go to the a.m. URL]